Blog

Certain genetic faults could help predict success of immunotherapy

Anne Li                                      6/9/17   A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. The research from…...

Read more

Combining immunotherapies could benefit some aggressive breast cancers

Anne Li                          6/9/17   Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.  Researchers at Walter and Eliza Hall Institute and Peter MacCallum Cancer Centre…...

Read more

New chemotherapy approach offers breast cancer patients a better quality of life

Anne Li                          6/9/17   The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin. These are the…...

Read more

Two clinical trials show promise with different targeted drugs for lung cancer

Anne LI                              6/9/17   Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials. The drug alectinib (Alecensa), which targets a faulty…...

Read more

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

Anne Li                               6/9/17   In 2012, the drug abiraterone (Zytiga) was first made available on the NHS to treat men with advanced prostate cancer that has stopped responding to standard hormone treatment. Now, a strong…...

Read more

Statement on the death of Professor Patrick Johnston

Anne Li                                    6/9/17   During the past week, the world has lost one of its leading cancer researchers- Professor Patrick Johnston. Here Sir Harpal Kumar, Cancer Research UK's chief executive commemorates the legacy…...

Read more

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

Anne LI                                     6/9/17   A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy, according to results from a clinical trial.…...

Read more

Combined immunotherapy could help control melanoma that has spread to the brain

Anne LI                            6/9/17   A combination of two immunotherapy drugs is safe to give to patients with melanoma, a type of skin cancer, that has spread to the brain, and could help control the disease. Melanomas that…...

Read more

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Anne Li                                        6/9/17   Offering a drug up-front with standard hormone treatment extends survival in men whose prostate cancer has spread, according to results from a late stage clinical trial. The…...

Read more

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Anne Li                              6/4/17   Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for…...

Read more